Year |
Citation |
Score |
2024 |
Zambrano P, Manrique-Moreno M, Petit K, Colina JR, Jemiola-Rzeminska M, Suwalsky M, Strzalka K. Differential scanning calorimetry in drug-membrane interactions. Biochemical and Biophysical Research Communications. 709: 149806. PMID 38579619 DOI: 10.1016/j.bbrc.2024.149806 |
0.753 |
|
2023 |
Zambrano P. Exploring Multitarget Strategies for Membrane Protection in Alzheimer's Disease. Acs Chemical Neuroscience. PMID 37874335 DOI: 10.1021/acschemneuro.3c00627 |
0.489 |
|
2023 |
Zambrano P, Jemiola-Rzeminska M, Muñoz-Torrero D, Suwalsky M, Strzalka K. A rhein-huprine hybrid protects erythrocyte membrane integrity against Alzheimer's disease related Aβ(1-42) peptide. Biophysical Chemistry. 300: 107061. PMID 37307659 DOI: 10.1016/j.bpc.2023.107061 |
0.791 |
|
2022 |
Zambrano P. On the interaction of a donepezil-huprine hybrid with synthetic membrane models. Neural Regeneration Research. 18: 333-334. PMID 35900422 DOI: 10.4103/1673-5374.343903 |
0.51 |
|
2021 |
Zambrano P, Suwalsky M, Jemiola-Rzeminska M, Gallardo-Nelson MJ, Strzalka K, Muñoz-Torrero D. Protective Role of a Donepezil-Huprine Hybrid against the β-Amyloid (1-42) Effect on Human Erythrocytes. International Journal of Molecular Sciences. 22. PMID 34502472 DOI: 10.3390/ijms22179563 |
0.732 |
|
2020 |
Zambrano P, Suwalsky M, Jemiola-Rzeminska M, Strzalka K, Aguilar LF. An in vitro study on the interaction of the anti-Alzheimer drug rivastigmine with human erythrocytes. Chemico-Biological Interactions. 319: 109019. PMID 32092302 DOI: 10.1016/j.cbi.2020.109019 |
0.793 |
|
2019 |
Zambrano P, Suwalsky M, Jemiola-Rzeminska M, Strzalka K, Sepúlveda B, Gallardo MJ, Aguilar LF. The acetylcholinesterase (AChE) inhibitor and anti-Alzheimer drug donepezil interacts with human erythrocytes. Biochimica Et Biophysica Acta. Biomembranes. 1861: 1078-1085. PMID 30904408 DOI: 10.1016/j.bbamem.2019.03.014 |
0.808 |
|
2018 |
Zambrano P, Suwalsky M, Jemiola-Rzeminska M, Strzalka K. α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes. Biochemical and Biophysical Research Communications. 503: 209-214. PMID 29879427 DOI: 10.1016/J.Bbrc.2018.06.004 |
0.759 |
|
2018 |
Zambrano P, Suwalsky M, Jemiola-Rzeminska M, Strzalka K. Studies on the interaction of NMDA receptor antagonist memantine with cell membranes: A mini-review. Chemico-Biological Interactions. 283: 47-50. PMID 29407462 DOI: 10.1016/j.cbi.2018.01.022 |
0.725 |
|
2017 |
Zambrano P, Suwalsky M, Villena F, Jemiola-Rzeminska M, Strzalka K. In vitro effects of the anti-Alzheimer drug memantine on the human erythrocyte membrane and molecular models. Biochemical and Biophysical Research Communications. 483: 528-533. PMID 27998775 DOI: 10.1016/j.bbrc.2016.12.111 |
0.8 |
|
2016 |
Suwalsky M, Zambrano P, Gallardo MJ, Villena F, Jemiola-Rzeminska M, Strzalka K. Effects of Thimerosal on Lipid Bilayers and Human Erythrocytes: An In Vitro Study. The Journal of Membrane Biology. 249: 823-831. PMID 27738716 DOI: 10.1007/s00232-016-9933-y |
0.739 |
|
2015 |
Suwalsky M, Zambrano P, Villena F, Manrique-Moreno M, Gallardo MJ, Jemiola-Rzeminska M, Strzalka K, Edwards AM, Mennickent S, Dukes N. Morphological Effects Induced In Vitro by Propranolol on Human Erythrocytes. The Journal of Membrane Biology. 248: 683-93. PMID 25724773 DOI: 10.1007/s00232-015-9780-2 |
0.799 |
|
2011 |
Suwalsky M, Zambrano P, Mennickent S, Villena F, Sotomayor CP, Aguilar LF, Bolognin S. Effects of phenylpropanolamine (PPA) on in vitro human erythrocyte membranes and molecular models. Biochemical and Biophysical Research Communications. 406: 320-5. PMID 21320467 DOI: 10.1016/j.bbrc.2011.01.117 |
0.791 |
|
Show low-probability matches. |